Professional Documents
Culture Documents
00 am
TENDER NO ITEM QUANTIT PACK DELIVERY
Y SIZE
LP/MSD/CPU- MSD O/L No 2019/SPC/B/C/P/00851 318 01 VIAL IMMEDIATELY
DHS/RQ/846/ SR No 01401701 VIALS with 15 months
(T)/2019 Residual Shelf
Item Infliximab Injection 100mg
Specification Infliximab injection powder for reconstitution 100mg Life
Each vial to contain 100mg of Infliximab (a chimeric human-murine
immunoglobulin
monoclonal antibody) manufactured from recombinant cell culture
as a powder for
reconstitution for intravenous infusion.
Note:
1. This injection should be stable for a minimum of 24
months when stored within temperature range of 2'C - 8'C.
2. Each vial should be labelled accordingly.
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00229 366 01 PFS 200 PFS
DHS/RQ/030/ SR No 01207401 PFSY 29/02/2020 AND
(E)/2020 166 PFS
Item Octreotide long acting injection 20mg vial with sovent
Specification Long-acting form of Octreotide 20mg vial with solvent 30/03/2020 with
Each vial to contain 20 mg of octreotide (as octreotide acetate) in 15 months
powder form for suspension for injection with solvent Residual Shelf
Note: Life
1.This injection should be stable for a minimum 24 months when
stored at a temperature range of 2'C - 8'C
2.Each vial should be labeled accordingly
TENDER NO ITEM QUANTIT PACK DELIVERY
Y SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00219 2,655 1 VIAL 1,655 VIALS -
DHS/RQ/032/ SR No 01202901 VIALS 29/02/2020 &
(E)/2020 1,000 VIALS -
Item Bevacizumab inj. 100mg/4mlvial
Specification Bevacizumab Injection 100mg/4ml 25/03/2020 with
Each 4ml vial to contain 100mg of Bevacizumab for intravenous 15 months
infusion. Residual Shelf
Note : Life
1.The product should be stable for a minimum of 24 months when
stored within a
temperature range of 2'C-8'C.
2.Each vial should be labelled accordingly.
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00218 3,472 1 CAPS 2,000 CAPS -
DHS/RQ/033/ SR No 01204701 CAPS 28/02/2020 &
(T)/2020 1,472 CAPS -
Item Sunitinib Malate capsule 50mg
Specification Sunitinib Malate capsules 50mg 25/03/2020 with
Each capsule to contain 50mg of Sunitinib Maleate. 15 months
Note: Residual Shelf
01.The shelf life of the product should be minimum of 24 months Life
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00214 18,800 1 TAB 10,000 TABS -
DHS/RQ/035/ SR No 01208101 TABS 28/02/2020 &
(T)/2020 8,800 TABS -
Item Pazopanib tablet 200mg
Specification Pazopanib tablet 200mg 25/03/2020 with
Each tablet to contain 200 mg Pazopanib (as hydrochloride) 15 months
Note: Residual Shelf
01.The shelf life of the product should be minimum of 24 months Life
TENDER NO ITEM QUANTIT PACK DELIVERY
Y SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00227 30,290 1 TAB 20,000 TABS -
DHS/RQ/036/ SR No 01204501 TABS 29/02/2020 &
(E)/2020 10,290 TABS -
Item Lapatinib tablet 250mg
Specification Lapatinib tablet 250mg 30/03/2020 with
Each tablet to contain 250mg of Lapatinib. 15 months
Note: Residual Shelf
01.The shelf life of the product should be minimum of 24 months Life
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00222 34,626 1 TAB 20,000 TABS -
DHS/RQ/037/ SR No 01211001 TABS 29/02/2020 &
(T)/2020 14,626 TABS -
Item Regorafenib tablet 40mg
Specification Regorafenib tablet 40mg 25/03/2020 with
Each film- coated tablet to contain 40mg of Regoafenib. 15 months
Note: Residual Shelf
The Shelf Life of the product should be minimum of 24 months Life
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00223 13,187 01 CAP 7,500 CAPS
DHS/RQ/039/ SR No 01211301 CAPS 29/02/2020 AND
(T)/2020 5,687 CAPS BY
Item Palbociclib Capsule 125mg
Specification Palbociclib Capsule 125mg 24/03/2020 with
15 months
Residual Shelf
Life
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00215 31,248 01 CAP 20,000 Caps
DHS/RQ/040/ SR No 01208902 CAPS 29/02/2020
(E)/2020 Balance
Item Nilotinib cap 200mg
Specification Nilotinib hydrochloride monohydrate capsule 200mg 26/03/2020 with
Each capsule to contain 200mg of Nilotinib (as hydrochloride 15 months
monohydrate) Residual Shelf
Note: Life
01.The shelf life of the product should be minimum of 24 months
TENDER NO ITEM QUANTIT PACK DELIVERY
Y SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00215 22,740 01 CAP 12,000 Caps
DHS/RQ/041/ SR No 01208901 CAPS 28/02/2020
(E)/2020 balance
Item Nilotinib cap 150mg
Specification Nilotinib hydrochloride monohydrate capsule 150mg 25/03/2020 with
Each capsule to contain 150mg of Nilotinib (as hydrochloride 15 months
monohydrate) Residual Shelf
Note: Life
01.The shelf life of the product should be minimum of 24 months
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00225 1,016 01 PFS 616 pfs by
DHS/NRQ/043/ SR No 01210501 PFSY 29/02/2020 ad
(E)/2020 balance by
Item Fulvestrant injection 250mg/5ml PFS
Specification Fulvestrant solution for injection 50mg/ml, 5ml pre-filled syringe 25/03/2020 with
Each pre-filled syringe to contain 250 mg of fulvestrant in 5 ml 15 months
solution. Residual Shelf
Note: Life
1.This injection should be stable for a minimum of 24 months when
stored within temperature range of 2?C ? 8?C.
2.Each pre-filled syringe should be labelled accordingly.
conditions to the Tender
UUJHYou are requested to indicate the lowest price in Sri Lankan Rupees that could be afforded.
A Certified copy of the National Medicines Regulation Authority (NMRA – Sri Lanka) Registration Certificate, Certificate of Analysis (COA) should be
forwarded along with the quotation.
Your quotation / quotations shall be placed in the relevant tender box; which is placed in the Internal Audit Department of the Head Office of the State
Pharmaceuticals Corporation. prior to closing date and time indicated above. (Any late delivered / submitted bids will be rejected without accepting)
Tender Samples, with clear indication of the Tender No, shall be handed over to the Administration Department on or before the closing of tender and
acknowledgement of such samples should be attached to the quotation (bid).
SPC reserves the right to call samples from bidders who have not submitted samples before closing of the tender in cases of none of the bidders had submitted
samples, evaluators are with the opinion of calling samples from bidders who have not submitted samples and / or the Procurement committee is with the
opinion of calling of samples from the bidders who have not submitted samples will help them to make a cost effective decision.
Note
1. Please indicate the current market whole sale and Retail prices in your quotation (bid)
2. Your Quotation (bid) shall be submitted in one original and one duplicate, sealed separately and marked as “ORIGINAL” and “DUPLICATE” respectively.
Both envelopes shall be enclosed in one envelop and deposited in the tender box kept in the Internal Audit Department.
3. In case if the supplier / manufacturer is not registered with NMRA – Sri Lanka, please provide following details together with the bid (Quotation)
i) GMP certificate
ii) Certificate of Pharmaceutical Products
iii) Manufacturer’s information letter
iv) Certificate of Analysis of the Product